iBio’s FastPharming featured in Genetic Engineering & Biotechnology News

iBio Inc. Logo

iBio’s (NYSE American:IBIO) plant-based FastPharming System and customized FastGlycaneering tools were featured in an article in Genetic Engineering & Biotechnology.

Sylvain Marcel, Ph.D., VP of protein expression sciences with iBio, discusses how the company’s technologies can expedite process development and support fast and cost-effective development of biotherapeutics for immuno-oncology.

According to Dr. Marcel, implementing a comprehensive glycoengineering strategy earlier in the screening process with support for rapid clinical development and commercial production offers a powerful tool for monoclonal antibody development in the treatment of cancer.

The article can be viewed here.

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.